Application 212322
- Type
- ANDA
- Sponsor
- AIZANT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EMPAGLIFLOZIN | EMPAGLIFLOZIN | TABLET;ORAL | 2.5MG | No | No |
| 002 | EMPAGLIFLOZIN | EMPAGLIFLOZIN | TABLET;ORAL | 10MG | No | No |
| 003 | EMPAGLIFLOZIN | EMPAGLIFLOZIN | TABLET;ORAL | 25MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jardiance | EMPAGLIFLOZIN | Aphena Pharma Solutions - Tennessee, LLC | 334f1b3d-5670-6685-e063-6294a90a7e47 | 2026-06-17 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | Cardinal Health 107, LLC | 5777b8a8-ada6-4950-8548-43a1de11f075 | 2026-02-17 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | Boehringer Ingelheim Pharmaceuticals, Inc. | faf3dd6a-9cd0-39c2-0d2e-232cb3f67565 | 2026-01-30 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | Aphena Pharma Solutions - Tennessee, LLC | 8b6261f6-4bdc-462e-8af1-4064664c62f3 | 2025-10-27 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| Jardiance | EMPAGLIFLOZIN | A-S Medication Solutions | a77214ca-572e-485e-aae9-f7950187e5fb | 2023-08-08 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | 942a82a4-cbbd-4e44-9965-8d03f767912b | 2023-07-24 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | 1782b947-4a72-4feb-a488-1469d9af82bd | 2023-05-03 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | f2b41c77-0abb-40ee-8578-86a748d0e19e | 2023-05-03 | Warnings, Adverse reactions | EMPAGLIFLOZIN |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 65882 | ORIG | 2021-01-12 |